| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BEEM.2015.10.011 |
| P698 | PubMed publication ID | 26696513 |
| P50 | author | Jennifer E Bruin | Q64674200 |
| Timothy J Kieffer | Q84264530 | ||
| P2093 | author name string | Jennifer E Bruin | |
| Nina Quiskamp | |||
| P2860 | cites work | Disease-specific induced pluripotent stem cells | Q24641981 |
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
| Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
| iPSC-derived β cells model diabetes due to glucokinase deficiency | Q36966930 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pluripotency | Q1894941 |
| P304 | page(s) | 833-847 | |
| P577 | publication date | 2015-10-30 | |
| P1433 | published in | Best Practice and Research: Clinical Endocrinology and Metabolism | Q15755890 |
| P1476 | title | Differentiation of human pluripotent stem cells into β-cells: Potential and challenges | |
| P478 | volume | 29 |
| Q27320218 | A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells |
| Q55262786 | A single cell high content assay detects mitochondrial dysfunction in iPSC-derived neurons with mutations in SNCA. |
| Q49852329 | Annual review issue: An overview of 50 years of progress in endocrine pathology |
| Q39069908 | Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus |
| Q50461576 | Differentiation of Islet Progenitors Regulated by Nicotinamide into Transcriptome-Verified β Cells That Ameliorate Diabetes |
| Q41689677 | Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells |
| Q26745523 | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| Q26749174 | Engineering the gut for insulin replacement to treat diabetes |
| Q46398292 | Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development |
| Q26742051 | Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology |
| Q57064373 | Human pluripotent stem cells for the modelling of pancreatic beta-cell pathology |
| Q57166646 | Immune Mechanisms and Pathways Targeted in Type 1 Diabetes |
| Q41051113 | Late-stage differentiation of embryonic pancreatic β-cells requires Jarid2 |
| Q38951189 | Mass production of functional human pancreatic β-cells: why and how? |
| Q37578248 | MiRNAs in β-Cell Development, Identity, and Disease. |
| Q52543005 | Regenerative medicine and cell-based approaches to restore pancreatic function. |
| Q39047508 | Synthetic Biology in Cell and Organ Transplantation |
| Q38912666 | The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds |
| Q42777668 | Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation |
| Q38828883 | β-cell differentiation status in type 2 diabetes. |
Search more.